| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $162.6M | +14.1% |
| R&D Expense | $2.0M | -20.0% |
| SG&A Expense | $57.8M | +2.3% |
| Operating Income | $4.3M | +178.2% |
| Pre-tax Income | $8.3M | +346.9% |
| Income Tax | $116K | +150.0% |
| Net Income | $6.6M | +309.1% |
| EPS (Basic) | $2.60 | +304.7% |
| EPS (Diluted) | $2.55 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.9M | +54.8% |
| Accounts Receivable | $31.5M | +31.4% |
| Inventory | $41.0M | -1.5% |
| Current Assets | $105.6M | +2.3% |
| Total Assets | $152.8M | +0.5% |
| Current Liabilities | $25.4M | -20.7% |
| Long-term Debt | $6.0M | -5.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.7M | +166.5% |
| Capital Expenditures | $1.3M | -30.4% |
| Investing Cash Flow | $479K | +128.5% |
| Financing Cash Flow | -$4.3M | -74.9% |
| Free Cash Flow | $11.4M | +294.7% |
| +300.8% |
| Total Liabilities |
| $36.7M |
| -13.9% |
| Stockholders' Equity | $98.8M | +7.9% |